Global Trastuzumab Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 107
Published Date: 04 Jan 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
According to our (Global Info Research) latest study, the global Trastuzumab Biosimilar market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
This report is a detailed and comprehensive analysis for global Trastuzumab Biosimilar market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Trastuzumab Biosimilar market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Trastuzumab Biosimilar market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Trastuzumab Biosimilar market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Trastuzumab Biosimilar market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Trastuzumab Biosimilar
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Trastuzumab Biosimilar market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen Inc., Pfizer Inc, Samsung Bioepis, Merck & Co. and Biocon Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Trastuzumab Biosimilar market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
Others
Market segment by Application
Hospital Pharmacy
Online Pharmacy
Major players covered
Amgen Inc.
Pfizer Inc
Samsung Bioepis
Merck & Co.
Biocon Limited
Teva Pharmaceutical
Genentech
Mundipharma
Celltrion
Henlius
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Trastuzumab Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Trastuzumab Biosimilar, with price, sales, revenue and global market share of Trastuzumab Biosimilar from 2018 to 2023.
Chapter 3, the Trastuzumab Biosimilar competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Trastuzumab Biosimilar breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Trastuzumab Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Trastuzumab Biosimilar.
Chapter 14 and 15, to describe Trastuzumab Biosimilar sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Trastuzumab Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Trastuzumab Biosimilar Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Adjuvant Breast Cancer
1.3.3 Metastatic Breast Cancer
1.3.4 Metastatic Gastric Cancer
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Trastuzumab Biosimilar Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacy
1.4.3 Online Pharmacy
1.5 Global Trastuzumab Biosimilar Market Size & Forecast
1.5.1 Global Trastuzumab Biosimilar Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Trastuzumab Biosimilar Sales Quantity (2018-2029)
1.5.3 Global Trastuzumab Biosimilar Average Price (2018-2029)
2.1 Amgen Inc.
2.1.1 Amgen Inc. Details
2.1.2 Amgen Inc. Major Business
2.1.3 Amgen Inc. Trastuzumab Biosimilar Product and Services
2.1.4 Amgen Inc. Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Amgen Inc. Recent Developments/Updates
2.2 Pfizer Inc
2.2.1 Pfizer Inc Details
2.2.2 Pfizer Inc Major Business
2.2.3 Pfizer Inc Trastuzumab Biosimilar Product and Services
2.2.4 Pfizer Inc Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Inc Recent Developments/Updates
2.3 Samsung Bioepis
2.3.1 Samsung Bioepis Details
2.3.2 Samsung Bioepis Major Business
2.3.3 Samsung Bioepis Trastuzumab Biosimilar Product and Services
2.3.4 Samsung Bioepis Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Samsung Bioepis Recent Developments/Updates
2.4 Merck & Co.
2.4.1 Merck & Co. Details
2.4.2 Merck & Co. Major Business
2.4.3 Merck & Co. Trastuzumab Biosimilar Product and Services
2.4.4 Merck & Co. Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co. Recent Developments/Updates
2.5 Biocon Limited
2.5.1 Biocon Limited Details
2.5.2 Biocon Limited Major Business
2.5.3 Biocon Limited Trastuzumab Biosimilar Product and Services
2.5.4 Biocon Limited Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Biocon Limited Recent Developments/Updates
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Product and Services
2.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Pharmaceutical Recent Developments/Updates
2.7 Genentech
2.7.1 Genentech Details
2.7.2 Genentech Major Business
2.7.3 Genentech Trastuzumab Biosimilar Product and Services
2.7.4 Genentech Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Genentech Recent Developments/Updates
2.8 Mundipharma
2.8.1 Mundipharma Details
2.8.2 Mundipharma Major Business
2.8.3 Mundipharma Trastuzumab Biosimilar Product and Services
2.8.4 Mundipharma Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mundipharma Recent Developments/Updates
2.9 Celltrion
2.9.1 Celltrion Details
2.9.2 Celltrion Major Business
2.9.3 Celltrion Trastuzumab Biosimilar Product and Services
2.9.4 Celltrion Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Celltrion Recent Developments/Updates
2.10 Henlius
2.10.1 Henlius Details
2.10.2 Henlius Major Business
2.10.3 Henlius Trastuzumab Biosimilar Product and Services
2.10.4 Henlius Trastuzumab Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Henlius Recent Developments/Updates
3.1 Global Trastuzumab Biosimilar Sales Quantity by Manufacturer (2018-2023)
3.2 Global Trastuzumab Biosimilar Revenue by Manufacturer (2018-2023)
3.3 Global Trastuzumab Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Trastuzumab Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Trastuzumab Biosimilar Manufacturer Market Share in 2022
3.4.2 Top 6 Trastuzumab Biosimilar Manufacturer Market Share in 2022
3.5 Trastuzumab Biosimilar Market: Overall Company Footprint Analysis
3.5.1 Trastuzumab Biosimilar Market: Region Footprint
3.5.2 Trastuzumab Biosimilar Market: Company Product Type Footprint
3.5.3 Trastuzumab Biosimilar Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Trastuzumab Biosimilar Market Size by Region
4.1.1 Global Trastuzumab Biosimilar Sales Quantity by Region (2018-2029)
4.1.2 Global Trastuzumab Biosimilar Consumption Value by Region (2018-2029)
4.1.3 Global Trastuzumab Biosimilar Average Price by Region (2018-2029)
4.2 North America Trastuzumab Biosimilar Consumption Value (2018-2029)
4.3 Europe Trastuzumab Biosimilar Consumption Value (2018-2029)
4.4 Asia-Pacific Trastuzumab Biosimilar Consumption Value (2018-2029)
4.5 South America Trastuzumab Biosimilar Consumption Value (2018-2029)
4.6 Middle East and Africa Trastuzumab Biosimilar Consumption Value (2018-2029)
5.1 Global Trastuzumab Biosimilar Sales Quantity by Type (2018-2029)
5.2 Global Trastuzumab Biosimilar Consumption Value by Type (2018-2029)
5.3 Global Trastuzumab Biosimilar Average Price by Type (2018-2029)
6.1 Global Trastuzumab Biosimilar Sales Quantity by Application (2018-2029)
6.2 Global Trastuzumab Biosimilar Consumption Value by Application (2018-2029)
6.3 Global Trastuzumab Biosimilar Average Price by Application (2018-2029)
7.1 North America Trastuzumab Biosimilar Sales Quantity by Type (2018-2029)
7.2 North America Trastuzumab Biosimilar Sales Quantity by Application (2018-2029)
7.3 North America Trastuzumab Biosimilar Market Size by Country
7.3.1 North America Trastuzumab Biosimilar Sales Quantity by Country (2018-2029)
7.3.2 North America Trastuzumab Biosimilar Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Trastuzumab Biosimilar Sales Quantity by Type (2018-2029)
8.2 Europe Trastuzumab Biosimilar Sales Quantity by Application (2018-2029)
8.3 Europe Trastuzumab Biosimilar Market Size by Country
8.3.1 Europe Trastuzumab Biosimilar Sales Quantity by Country (2018-2029)
8.3.2 Europe Trastuzumab Biosimilar Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Trastuzumab Biosimilar Market Size by Region
9.3.1 Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Trastuzumab Biosimilar Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Trastuzumab Biosimilar Sales Quantity by Type (2018-2029)
10.2 South America Trastuzumab Biosimilar Sales Quantity by Application (2018-2029)
10.3 South America Trastuzumab Biosimilar Market Size by Country
10.3.1 South America Trastuzumab Biosimilar Sales Quantity by Country (2018-2029)
10.3.2 South America Trastuzumab Biosimilar Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Trastuzumab Biosimilar Market Size by Country
11.3.1 Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Trastuzumab Biosimilar Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Trastuzumab Biosimilar Market Drivers
12.2 Trastuzumab Biosimilar Market Restraints
12.3 Trastuzumab Biosimilar Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Trastuzumab Biosimilar and Key Manufacturers
13.2 Manufacturing Costs Percentage of Trastuzumab Biosimilar
13.3 Trastuzumab Biosimilar Production Process
13.4 Trastuzumab Biosimilar Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Trastuzumab Biosimilar Typical Distributors
14.3 Trastuzumab Biosimilar Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Trastuzumab Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Trastuzumab Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Inc. Major Business
Table 5. Amgen Inc. Trastuzumab Biosimilar Product and Services
Table 6. Amgen Inc. Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Amgen Inc. Recent Developments/Updates
Table 8. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Inc Major Business
Table 10. Pfizer Inc Trastuzumab Biosimilar Product and Services
Table 11. Pfizer Inc Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Inc Recent Developments/Updates
Table 13. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 14. Samsung Bioepis Major Business
Table 15. Samsung Bioepis Trastuzumab Biosimilar Product and Services
Table 16. Samsung Bioepis Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Samsung Bioepis Recent Developments/Updates
Table 18. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co. Major Business
Table 20. Merck & Co. Trastuzumab Biosimilar Product and Services
Table 21. Merck & Co. Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck & Co. Recent Developments/Updates
Table 23. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 24. Biocon Limited Major Business
Table 25. Biocon Limited Trastuzumab Biosimilar Product and Services
Table 26. Biocon Limited Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Biocon Limited Recent Developments/Updates
Table 28. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Major Business
Table 30. Teva Pharmaceutical Trastuzumab Biosimilar Product and Services
Table 31. Teva Pharmaceutical Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Pharmaceutical Recent Developments/Updates
Table 33. Genentech Basic Information, Manufacturing Base and Competitors
Table 34. Genentech Major Business
Table 35. Genentech Trastuzumab Biosimilar Product and Services
Table 36. Genentech Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Genentech Recent Developments/Updates
Table 38. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 39. Mundipharma Major Business
Table 40. Mundipharma Trastuzumab Biosimilar Product and Services
Table 41. Mundipharma Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mundipharma Recent Developments/Updates
Table 43. Celltrion Basic Information, Manufacturing Base and Competitors
Table 44. Celltrion Major Business
Table 45. Celltrion Trastuzumab Biosimilar Product and Services
Table 46. Celltrion Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Celltrion Recent Developments/Updates
Table 48. Henlius Basic Information, Manufacturing Base and Competitors
Table 49. Henlius Major Business
Table 50. Henlius Trastuzumab Biosimilar Product and Services
Table 51. Henlius Trastuzumab Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Henlius Recent Developments/Updates
Table 53. Global Trastuzumab Biosimilar Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Trastuzumab Biosimilar Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Trastuzumab Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 56. Market Position of Manufacturers in Trastuzumab Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Trastuzumab Biosimilar Production Site of Key Manufacturer
Table 58. Trastuzumab Biosimilar Market: Company Product Type Footprint
Table 59. Trastuzumab Biosimilar Market: Company Product Application Footprint
Table 60. Trastuzumab Biosimilar New Market Entrants and Barriers to Market Entry
Table 61. Trastuzumab Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Trastuzumab Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Trastuzumab Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Trastuzumab Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Trastuzumab Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Trastuzumab Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 67. Global Trastuzumab Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 68. Global Trastuzumab Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Trastuzumab Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Trastuzumab Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Trastuzumab Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Trastuzumab Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 73. Global Trastuzumab Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 74. Global Trastuzumab Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Trastuzumab Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Trastuzumab Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Trastuzumab Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Trastuzumab Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Trastuzumab Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 80. North America Trastuzumab Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Trastuzumab Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Trastuzumab Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Trastuzumab Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Trastuzumab Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Trastuzumab Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Trastuzumab Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Trastuzumab Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Trastuzumab Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Trastuzumab Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Trastuzumab Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Trastuzumab Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Trastuzumab Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Trastuzumab Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Trastuzumab Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Trastuzumab Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Trastuzumab Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Trastuzumab Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Trastuzumab Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Trastuzumab Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Trastuzumab Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Trastuzumab Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Trastuzumab Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Trastuzumab Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Trastuzumab Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Trastuzumab Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Trastuzumab Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Trastuzumab Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Trastuzumab Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Trastuzumab Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Trastuzumab Biosimilar Raw Material
Table 121. Key Manufacturers of Trastuzumab Biosimilar Raw Materials
Table 122. Trastuzumab Biosimilar Typical Distributors
Table 123. Trastuzumab Biosimilar Typical Customers
List of Figures
Figure 1. Trastuzumab Biosimilar Picture
Figure 2. Global Trastuzumab Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Trastuzumab Biosimilar Consumption Value Market Share by Type in 2022
Figure 4. Adjuvant Breast Cancer Examples
Figure 5. Metastatic Breast Cancer Examples
Figure 6. Metastatic Gastric Cancer Examples
Figure 7. Others Examples
Figure 8. Global Trastuzumab Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Trastuzumab Biosimilar Consumption Value Market Share by Application in 2022
Figure 10. Hospital Pharmacy Examples
Figure 11. Online Pharmacy Examples
Figure 12. Global Trastuzumab Biosimilar Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Trastuzumab Biosimilar Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Trastuzumab Biosimilar Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Trastuzumab Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Trastuzumab Biosimilar Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Trastuzumab Biosimilar Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Trastuzumab Biosimilar by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Trastuzumab Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Trastuzumab Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Trastuzumab Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Trastuzumab Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Trastuzumab Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Trastuzumab Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Trastuzumab Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Trastuzumab Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Trastuzumab Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Trastuzumab Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Trastuzumab Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Trastuzumab Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Trastuzumab Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Trastuzumab Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Trastuzumab Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Trastuzumab Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Trastuzumab Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Trastuzumab Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Trastuzumab Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Trastuzumab Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Trastuzumab Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Trastuzumab Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Trastuzumab Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Trastuzumab Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Trastuzumab Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Trastuzumab Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Trastuzumab Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 54. China Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Trastuzumab Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Trastuzumab Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Trastuzumab Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Trastuzumab Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Trastuzumab Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Trastuzumab Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Trastuzumab Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Trastuzumab Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Trastuzumab Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Trastuzumab Biosimilar Market Drivers
Figure 75. Trastuzumab Biosimilar Market Restraints
Figure 76. Trastuzumab Biosimilar Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Trastuzumab Biosimilar in 2022
Figure 79. Manufacturing Process Analysis of Trastuzumab Biosimilar
Figure 80. Trastuzumab Biosimilar Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Amgen Inc. Pfizer Inc Samsung Bioepis Merck & Co. Biocon Limited Teva Pharmaceutical Genentech Mundipharma Celltrion Henlius
Related Reports
29 Jan 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
